Squalestatin1 (SQ1), a potent inhibitor of squalene synthase produced a dose-dependent induction of cytochromes P450 CYP2H1 and CYP3A37 mRNAs in chicken hepatoma cells. The effect of SQ1 was completely reversed by 25-hydroxycholesterol. Bile acids elicited an induction of CYP3A37 and CYP2H1 mRNA. Bile acids also reduced the phenobarbital induction of CYP2H1 but not of CYP3A37 mRNA. The effects of SQ1 and its reversal by 25-hydroxycholesterol and the effects of bile acids were reproduced in reporter gene assays with a phenobarbital-responsive enhancer unit of CYP2H1. These data suggest that an endogenous molecule related to cholesterol homeostasis regulates induction of drug-inducible CYPs.
INTRODUCTION
Drug-mediated induction of cytochrome P450 hemeproteins (CYPs) has major effects on the biotransformation of endogenous and exogenous molecules including steroid hormones, bile acids, leukotrienes and xenobiotics such as most drugs. Phenobarbital (PB) is the prototype of a large group of small, lipophilic molecules regulating the drug-and steroid-metabolizing CYP2B, CYP2C and CYP3A subfamilies (1, 2) . PB induction is observed in all species including plants, fish, birds, insects and mammals, with the notable exception of yeast (3) . These observations have led us to speculate that PB induction of CYPs involves an endogenous regulation common to all living organisms (4) . Recently, enhancer regions in the 5'-flanking region of PB-inducible CYPs have been isolated in chicken, rat, mouse and humans and DNA-binding proteins associated with these elements have been identified (for reviews, see refs. 1, 5) . Members of the nuclear receptor superfamily, in particular the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) in mammals (1) and the chicken xenobiotic receptor (CXR) (6) are transcription factors that mediate the drug-response. These receptors have considerable overlap in their inducer profiles and can interchangeably bind to their respective response elements even across species boundaries (7) . Interestingly, CAR, PXR and CXR belong to the family of orphan nuclear receptors comprising also receptors involved in cholesterol homeostasis, namely the oxysterol receptor LXR (liver X receptor) and the bile acid receptor (BAR, alternatively also designated FXR) (8) . Moreover, all these receptors form heterodimers with the retinoid X receptor (RXR) for binding to their recognition sequences.
In the absence of uptake of exogenous cholesterol, intracellular cholesterol content is controlled via two interconnected pathways. The mevalonate pathway ensures the de novo synthesis of cholesterol from acetyl-coA whereas the bile acid pathway transforms cholesterol into Page 5 of 22 hydroxylated metabolites leading to the primary bile acids, chenodeoxycholic acid (CCA) and cholic acid (CA) (reviewed in refs. 9-11). The regulation of both pathways occurs via negative feedback control loops activated by their respective end products (cholesterol or oxysterols for the mevalonate pathway, and bile acids for cholesterol catabolism). The pathways are interconnected by the stimulatory action of oxysterols in the catabolic pathway via LXR (12) and the activation of BAR by bile acids which leads to inhibition of cholesterol metabolism (13, 14) .
Previous observation by Kocarek et al. (15) with lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in rat hepatocyte primary cultures suggested a link between cholesterol homeostasis and regulation of drug-metabolizing enzymes. More recently, squalestatin1 (SQ1), a potent squalene synthase inhibitor was observed to induce the expression of PB-inducible rat CYPB1/B2, both in vivo and in vitro in rat hepatocytes (16) . Moreover, the effect of SQ1 was reversed by oxysterols. However, the mechanism of this interaction remained unexplained. We therefore have further investigated the effects of SQ1, oxysterols and bile acids on CYP induction.
In the experiments described here, we have compared the effect of SQ1, oxysterols and bile acids on both the basal and inducible expression of representatives of two avian PB-inducible CYP subfamilies, CYP2H1 and CYP3A37, in a chicken hepatoma cell line (LMH). These cells retain the unique property of being inducible by PB-type xenobiotics in contrast to mammalian hepatoma cells (7) . We show that SQ1 potently induces both CYPs and shares signalling pathways with the PB regulation of these genes. Moreover, we discovered that bile acids also induce CYP2H1 and confirm recent data in mammals that bile acids regulate CYP3A (17, 18) . Cell culture conditions and transfection: LMH cells were cultured and transfected as described previously (7) . For induction experiments, cells were seeded at 80-90% confluence and after attachment, maintained in fetal calf serum deprived medium for 48 hours in order to eliminate any cholesterol exogenous sources. During this period, the medium was renewed at least once. Cells were then treated with the inducers at the indicated concentrations in serum-free medium. After 16 or 24 hours incubation, cells were collected using the Trizol reagent's manufacturer procedure. Lysates were cleared by centrifugation and assayed for luciferase activity with the Luciferase Assay System (Promega) and -gal activity with the substrate chlorophenol red--Dgalactopyranoside. Luciferase values normalised to the -gal activity in the extracts are referred to as luciferase units. For CAT containing constructs, cells were harvested using the protocol and reagents of the CAT-ELISA kit (Roche Diagnostics, Rotkreuz, Switzerland). Protein content of the cell extracts were also measured for the determination of the relative protein concentrations Page 9 of 22 using the ESL protein assay (Roche Diagnostics, Rotkreuz, Switzerland). This value was used for normalisation of specific CAT expression to total protein content.
RNA isolation and semiquantitative PCR analysis:

RESULTS
SQ1 is an inducer of CYP2H1 and CYP3A37 mRNAs in LMH cells. LMH cells were maintained in chemically defined medium and in the absence of fetal calf serum at confluency for several days without visible toxicity. Under these conditions, LMH cells were treated with various doses of PB and SQ1. PB induced the mRNA of both CYP2H1 and CYP3A37 in a dosedependent manner, as previously described (19, 20) . SQ1 induced the mRNA of both genes with a nearly maximal effect at 1 M, the induction of CYP2H1 by SQ1 was approximately one-third of the response to PB, whereas CYP3A37 mRNA was induced to equal levels by both inducers.
When LMH cells were cultured in the presence of 10% fetal calf serum (FCS), PB induction was unchanged, but the SQ1 effect was much lower, showing a weak activation of CYP2H1 only at 10 M (data not shown). In the absence of serum, SQ1 thus is the most potent inducer of CYP2H1 and CYP3A37 so far known with an effect in the low micromolar range in LMH cells (Fig. 1A) . (Fig. 1B) . (Fig.   2 ). This activation was reversed by coincubation with increasing concentrations of 25 OHC. PB had no effect on reporter gene expression (data not shown). These data indicate that SQ1 effectively blocks cholesterol production in LMH cells.
Control of cholesterol depletion in LMH cells
Bile acids are regulators of CYP expression: CCA and CA are the two major primary bile acids formed from cholesterol both in mammals and chicken (21, 22) . CCA and CA have a regulatory role in cholesterol homeostasis by activating the bile acid receptor BAR and this affects the expression of CYP7A. CYP7A is the rate-limiting enzyme in bile acid formation, catalysing the biotransformation of cholesterol to 7-hydroxycholesterol. LMH cells were treated with bile acids alone or in combination with SQ1 and PB. Surprisingly, the effect on CYP2H1 and CYP3A37 mRNA was opposite. CCA and CA had little effect on CYP2H1 mRNA except at 100 M where they induce its mRNA several fold (Fig.3A) . Moreover, when incubated together with SQ1 or PB, bile acids produced a dose-dependent inhibition of induction. In contrast, CYP3A37 mRNA was strongly induced by bile acids (Fig.3B) . In particular, CCA (50 M) induced higher levels of CYP3A37 mRNA than SQ1 or PB at 50 M. CCA did not influence the effects of SQ1 or PB at concentrations below 20 M but induced CYP3A37 mRNA in an additive fashion at higher concentrations. CA has a similar but weaker effect (Fig.   3B ).
Squalestatin1 and bile acid effects act at the transcriptional level:
We have defined a regulatory element in the 5' flanking region of the CYP2H1 gene (19) . This element spans 264bp
and is located at approximately -1600bp upstream of the transcription start site of CYP2H1 and Page 12 of 22 is responsive to PB. It contains a DR4 like motif neighbouring a putative nuclear factor-1 (NF-1)
site. This motif is common to other PBRUs found in PB-regulated genes (7, 19, 23) . SQ1 transactivated this element and 25 OHC completely abolished this effect (Fig. 4A ). At the reporter gene level, the effect of PB also was partially inhibited by oxysterols. When bile acids were incubated with transfected cells, a weak activation of reporter gene expression was observed with CCA alone as at the mRNA level (Fig.4B) . Coexposure to CCA and PB resulted in an inhibition of PB induction to the level of CCA alone. Page 
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DISCUSSION
The data presented here demonstrate that cholesterol homeostasis regulators such as bile acids and oxysterols affect both the basal and induced levels of two drug-inducible CYPs, namely CYP2H1 and CYP3A37. This is demonstrated by results obtained at the mRNA level in LMH cells, a hepatoma cell line that uniquely maintains PB-type induction of several cytochromes P450 (7, 19) . In these cells, SQ1, an inhibitor of squalene formation and thereby cholesterol synthesis, is the most potent inducer of CYP2H1 and CYP3A37 so far tested. SQ1 has been chosen as an inhibitor of cholesterol biosynthesis because of its high specificity for squalene synthase, a late enzyme in the mevalonate pathway. SQ1 inhibition affects specifically the sterol production in the cell in contrast to the multiple effects of so-called "statins" such as lovastatin (16) . SQ1 induced CYP2H1, but also CYP3A37, a typical member of the CYP3A subfamily (20) . SQ1 indirectly or directly activated a PBRU of 264 bp in reporter gene assays (19) , imitating the effects of phenobarbital-type inducers. The fact that the effect of SQ1 on mRNA and on PBRU is reversed by oxysterols suggests an indirect mechanism. The data also suggest that SQ1 and PB are acting on CYP2H1 and CYP3A37 via a different mechanisms because the effect of PB is not reversed by oxysterols. Induction by SQ1 correlates with its inhibitory action on cholesterol biosynthesis as evidenced by activation of SREBPs, which also is fully reversed by oxysterols. We therefore hypothesise that endogenous sterols (such as hydroxycholesterol derivatives) negatively regulate the transcription of these CYP genes by interaction with the PBRU. It is of interest that no canonical SRE elements are contained in this sequence. Oxysterols transactivate the nuclear receptor LXR which binds to a nuclear receptor hexamer repeat sequence arranged as direct repeat spaced by 4 nucleotides (DR4) (24) . Indeed, the 264bp PBRU contains a DR4 element as a recognition site for CXR that is involved in PB-responsiveness (6, 19) . This avian PBRU also recognises the mammalian receptors CAR and PXR which all form Page 14 of 22 heterodimers with RXR for binding to this element and in all cases, a DR4 element is of importance (6, 7) . Thus, there may be competition between CXR/RXR and LXR/RXR and this could explain that the PB-induction of CYP2H1 is dependent on oxysterol levels. We are testing this hypothesis at present.
The effect of bile acids is more pronounced with CYP3A than with CYP2H1 and confirms recent results that some mammalian CYPs, e.g. CYP3A4 are induced by bile acids (17, 18) . Primary bile acids are major products of cholesterol catabolism, synthesised specifically in the hepatocyte (21) . These compounds have detergent properties and consequently, their accumulation is potentially deleterious for cells. Metabolism of bile acids to non-toxic, excretable products may represent an adaptable protective pathway against this toxicity (25) . The concentrations of the primary bile acids used in our experiments correspond to the concentrations occurring in bile.
The dose-dependent effect of bile acids on CYP3A37 induction could thus be a detoxification reaction similar to the protective effect of drug metabolism against drug toxicity. The effect of bile acids on CYP2H1 appears to be more difficult to interpret. At low concentrations (10 M), the inducibility of CYP2H1 and CYP3A37 by SQ1 or PB is inhibited. At higher concentrations (100 M), this effect appears to be compensated by induction of these enzymes. The inhibitory effect of bile acids differs from that of 25 OHC because it affects both SQ1 and PB induction. 
